Approach to the Patient with Non-cardiogenic Chest Pain of Esophageal Origin
Abstract
Non-cardiac chest pain is defined as the presence of recurrent retrosternal pain in which cardiovascular etiology has been objectively ruled out. Its overall prevalence in the community is estimated to be 13%. In this review we will focus on esophageal causes of chest pain, which rank first among non-cardiac causes. Currently available diagnostic tools to evaluate chest pain related to esophageal disorders include: therapeutic trials with proton pump inhibitors, upper gastrointestinal videoendoscopy, ambulatory reflux monitoring and high-resolution esophageal manometry. Treatment should be directed at the underlying pathophysiological mechanism responsible for the symptoms. Therapeutic options include drugs (proton pump inhibitors and neuromodulators), endoscopic treatment, surgery, and psychological therapies.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.